Artykuły w czasopismach na temat „Approval stage”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Approval stage”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Kochan, Iryna. "Ukrainian Terminology: Approval Stage." Terminological Bulletin, no. 5 (2019): 25–32. http://dx.doi.org/10.37919/2221-8807-2019-5-3.
Pełny tekst źródłaOliveira, Bruna Andrade dos Santos, Lucas de Oliveira Bernardes, Adriano Menis Ferreira, et al. "Impact of Educational Intervention on Cleaning and Disinfection of an Emergency Unit." International Journal of Environmental Research and Public Health 17, no. 9 (2020): 3313. http://dx.doi.org/10.3390/ijerph17093313.
Pełny tekst źródłaReddy, D. Samba. "An Overview of Novel Drugs and New Chemical Entities in 2013." International Journal of Pharmaceutical Sciences and Nanotechnology 7, no. 3 (2014): 2505–8. http://dx.doi.org/10.37285/ijpsn.2014.7.3.1.
Pełny tekst źródła&NA;. "Mitoxantrone nearing approval for late-stage prostate cancer." Inpharma Weekly &NA;, no. 1055 (1996): 22. http://dx.doi.org/10.2165/00128413-199610550-00046.
Pełny tekst źródłaFrantz, John A. "Two-stage drug approval would reduce the risks." Nature 435, no. 7039 (2005): 143. http://dx.doi.org/10.1038/435143b.
Pełny tekst źródłaCaggiano, Vincent, and Carol Parise. "Who gets treated at commission on cancer-approved programs and does it make a difference in survival?" Journal of Clinical Oncology 31, no. 26_suppl (2013): 114. http://dx.doi.org/10.1200/jco.2013.31.26_suppl.114.
Pełny tekst źródłaDawood, S. S., C. Albaracin, A. Gonzalez-Angulo, M. Markman, and B. Hennessy. "Effect of introduction of paclitaxel on survival among women with stage III and IV ovarian cancer." Journal of Clinical Oncology 27, no. 15_suppl (2009): 5536. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.5536.
Pełny tekst źródłaDiMasi, Joseph A., and Henry G. Grabowski. "Economics of New Oncology Drug Development." Journal of Clinical Oncology 25, no. 2 (2007): 209–16. http://dx.doi.org/10.1200/jco.2006.09.0803.
Pełny tekst źródła&NA;. "FDA Approval for Zykadia for Late-Stage Lung Cancer." Oncology Times 36, no. 10 (2014): 8. http://dx.doi.org/10.1097/01.cot.0000450371.08810.54.
Pełny tekst źródłaHarris, Tina. "Gaining approval for clinical research in third stage management." British Journal of Midwifery 6, no. 8 (1998): 532–34. http://dx.doi.org/10.12968/bjom.1998.6.8.532.
Pełny tekst źródłaSofaer, Neema, and Nir Eyal. "Translational Research Beyond Approval: A Two-Stage Ethics Review." American Journal of Bioethics 10, no. 8 (2010): W1—W3. http://dx.doi.org/10.1080/15265161.2010.500199.
Pełny tekst źródłaAhmed, Sagheer. "Lessons from the Aducanumab Approval Saga." Molecular Medicine Communications 2, no. 01 (2022): 01. http://dx.doi.org/10.55627/mmc.002.001.0077.
Pełny tekst źródłaKipli, Kumalasari, Fara Diva Mustapa, Shariffah Zatil Hidayah Syed Jamaluddin, and Favilla Zaini. "KNOWLEDGE MANAGEMENT PROCESS IMPLEMENTATION IN PRIVATE FINANCE INITIATIVE PROJECT IN MALAYSIA." Journal of Information System and Technology Management 6, no. 24 (2021): 109–17. http://dx.doi.org/10.35631/jistm.624011.
Pełny tekst źródłaMaria, Sylvia Macchione Saes. "Editorial Facing the challenge of the desk review approval." RAUSP Management Journal 53, no. 2 (2018): 139–40. https://doi.org/10.5281/zenodo.2602129.
Pełny tekst źródłaD., Sarika Prathyusha* Brahmaiah Bonthagarala M.V. Ngabhushanam and D. Nagarjuna Reddy. "MARKETING AUTHORIZATION PROCESS OF NEW DRUG SUBSTANCES IN U.S.A AND EUROPE." Indo American Journal of Pharmaceutical Sciences 04, no. 06 (2017): 1690–98. https://doi.org/10.5281/zenodo.821854.
Pełny tekst źródłaCoerver, Katherine, Melissa M. Yu, Anelyssa D'Abreu, Marc Wasserman, and Kavita V. Nair. "Practical Considerations in the Administration of Aducanumab for the Neurologist." Neurology: Clinical Practice 12, no. 2 (2021): 169–75. http://dx.doi.org/10.1212/cpj.0000000000001144.
Pełny tekst źródła&NA;. "FDA Approval for Cetuximab for Late-Stage Head & Neck Cancer." Oncology Times 33, no. 23 (2011): 24. http://dx.doi.org/10.1097/01.cot.0000410211.22294.ce.
Pełny tekst źródłaVytovtov, Aleksey, Andrey Kalach, and Pavel Ageev. "FIRE PROTECTION SYSTEMS EXAMINATION AT THE SPECIAL TECHNICAL CONDITIONS APPROVAL STAGE." Problems of risk management in the technosphere 2024, no. 4 (2024): 51–61. https://doi.org/10.61260/1998-8990-2025-2024-4-51-61.
Pełny tekst źródłaIurash, I. "Peace agreements at certain stages of the civil process." Uzhhorod National University Herald. Series: Law 1, no. 78 (2023): 251–56. http://dx.doi.org/10.24144/2307-3322.2023.78.1.40.
Pełny tekst źródłaLamba, Nayan, Timothy Smith, and Bryan Iorgulescu. "IMMU-02. THE SURVIVAL OUTCOMES ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITORS FOR NON-SMALL CELL LUNG CARCINOMA PATIENTS WITH BRAIN METASTASES IN THE UNITED STATES." Neuro-Oncology 22, Supplement_2 (2020): ii104—ii105. http://dx.doi.org/10.1093/neuonc/noaa215.433.
Pełny tekst źródłaMendenhall, William M., Stephanie Smith, Christopher G. Morris, et al. "Insurance Coverage for Adjuvant Proton Therapy in the Definitive Treatment of Breast Cancer." International Journal of Particle Therapy 6, no. 2 (2019): 26–30. http://dx.doi.org/10.14338/ijpt-19-00070.1.
Pełny tekst źródłaZou, Denise, Eileen Zhang, Sherry Wu, and Virgil Rose. "Use of Single-Arm Trials in FDA Approvals of Treatments in Relapsed or Refractory B-Cell Lymphoma." Blood 142, Supplement 1 (2023): 7250. http://dx.doi.org/10.1182/blood-2023-189855.
Pełny tekst źródłaWhite, Richard L., Sally Jeanne Trufan, Nicole Lee Gower, Brittany Neelands, and Asim Amin. "Disparities in use of immunotherapy for stage III and IV melanoma patients." Journal of Clinical Oncology 38, no. 15_suppl (2020): e19087-e19087. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e19087.
Pełny tekst źródłaBekimbetova, G. "ANALYSIS AND EVALUATION OF THE EFFICIENCY OF INVESTMENT PROJECTS IN THE REPUBLIC OF UZBEKISTAN." Slovak international scientific journal, no. 63 (May 10, 2022): 30–34. https://doi.org/10.5281/zenodo.6535033.
Pełny tekst źródłaKuzmin, Stanislav E. "Mergers and Acquisitions of Joint Stock Companies in Russia and Corporations in the US (legal regulation experience)." Moscow Journal of International Law 96, no. 4 (2014): 163–74. http://dx.doi.org/10.24833/0869-0049-2014-4-163-174.
Pełny tekst źródłaFedoreshchenko, Nikolay, and Mihail Levitin. "PRELIMINARY ANALYSIS OF THE MODERNIZATION OF METAL-CUTTING MACHINES." Bulletin of the Angarsk State Technical University 1, no. 15 (2022): 78–81. http://dx.doi.org/10.36629/2686-777x-2021-1-15-78-81.
Pełny tekst źródłaRafi, Achmad, Muharman Lubis, R. Wahjoe Witjaksono, and Nguyen Kieu Trang. "Development Of Means Of Engagement (Moe) Concepts For The Use Of Enterprise Resource Planning (Erp) At The Approval Level." Electronic Integrated Computer Algorithm Journal 1, no. 1 (2023): 32–40. http://dx.doi.org/10.62123/enigma.v1i1.4.
Pełny tekst źródłaCurtin, Nicola J. "The Development of Rucaparib/Rubraca®: A Story of the Synergy Between Science and Serendipity." Cancers 12, no. 3 (2020): 564. http://dx.doi.org/10.3390/cancers12030564.
Pełny tekst źródłaElen, Elen. "Mombolasuako Perspektif Istihsan Studi di Kecamatan Loea Kabupaten Kolaka Timur." KALOSARA: Family Law Review 4, no. 2 (2024): 101. https://doi.org/10.31332/kalosara.v4i2.5225.
Pełny tekst źródłaMulesa, Oksana, Yurii Bilak, Yevhenii Kykyna, and Dmytro Ferens. "Development of decision approval rules in multichannel decision-making systems." Technology audit and production reserves 6, no. 2(62) (2021): 6–9. http://dx.doi.org/10.15587/2706-5448.2021.244665.
Pełny tekst źródłaJung, Sun-Kyu, Won-Chang Kim, Gyu-Yong Kim, and Tae-Gyu Lee. "Improving Building Permit System via Case Analysis of Temporary Buildings in Industrial Facilities." Fire Science and Engineering 38, no. 3 (2024): 18–24. http://dx.doi.org/10.7731/kifse.c0d94c1a.
Pełny tekst źródłaRaitt, Petrina, and Stacey Fidgeon. "Competency framework: environmental approval specialists." APPEA Journal 59, no. 2 (2019): 698. http://dx.doi.org/10.1071/aj18172.
Pełny tekst źródłaLamba, Nayan, and Bryan Iorgulescu. "196 Checkpoint blockade therapy for brain-metastatic non-small cell lung cancer: a comparative effectiveness analysis of national data." Journal for ImmunoTherapy of Cancer 8, Suppl 3 (2020): A211. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0196.
Pełny tekst źródłaGhisa, Claudia, and Kenneth R. Zaslav. "Novel Treatment Options for Knee Cartilage Defects in 2023." Sports Medicine and Arthroscopy Review 32, no. 2 (2024): 113–18. http://dx.doi.org/10.1097/jsa.0000000000000398.
Pełny tekst źródłaGromova, Mariya, Annegret Vaggelas, Gabriele Dallmann, and Diane Seimetz. "Biomarkers: Opportunities and Challenges for Drug Development in the Current Regulatory Landscape." Biomarker Insights 15 (January 2020): 117727192097465. http://dx.doi.org/10.1177/1177271920974652.
Pełny tekst źródłaOksana, Mulesa, Bilak Yurii, Kykyna Yevhenii, and Ferens Dmytro. "Development of decision approval rules in multichannel decision-making systems." Technology Audit and Production Reserves 6, no. 2(62) (2021): 6–9. https://doi.org/10.15587/2706-5448.2021.244665.
Pełny tekst źródłaPowell, Kerrington, and V. Prasad. "Concerning FDA approval of trilaciclib (Cosela) in extensive-stage small-cell lung cancer." Translational Oncology 14, no. 11 (2021): 101206. http://dx.doi.org/10.1016/j.tranon.2021.101206.
Pełny tekst źródłaDanese, Silvio, Elmer Schabel, Mark Andrew Ainsworth, and Laurent Peyrin-Biroulet. "Challenges and opportunities for IBD drug development: from early stage to regulatory approval." Gut 69, no. 7 (2020): 1157–61. http://dx.doi.org/10.1136/gutjnl-2019-320542.
Pełny tekst źródłaOliveira, Ana Paula Cavalcante de, Ana Beatriz Zanardo Mion, Helen Fernanda Barbosa Batista, et al. "Prioritization criteria in policies and management of human resources for health: a proposal for a validated methodology." Revista Panamericana de Salud Pública 48 (May 2, 2024): 1. http://dx.doi.org/10.26633/rpsp.2024.39.
Pełny tekst źródłaSofia, Natalia, Stefan Mühlebach, Umberto M. Musazzi, et al. "How Do Hospital Pharmacists Approach Substitution of Nanomedicines? Insights from a Qualitative Pilot Study and a Quantitative Market Research Analysis in Five European Countries." Pharmaceutics 13, no. 7 (2021): 1010. http://dx.doi.org/10.3390/pharmaceutics13071010.
Pełny tekst źródłaMurphy, David S., and Scott Yetmar. "Petty Corruption in a Multi-Person, Multi-Stage Bureaucratic Process: Formal Models and an Experimental Assessment." Research in Economics and Management 4, no. 1 (2019): 69. http://dx.doi.org/10.22158/rem.v4n1p69.
Pełny tekst źródłaVOLKOV, ARTEM. "WAYS OF PROTECTING THE RIGHTS OF PERSONS INVOLVED IN CRIMINAL PROCEEDINGS AT THE STAGE OF APPROVAL BY THE PROSECUTOR OF THE ACT ENDING THE PRELIMINARY INVESTIGATION WITH SENDING THE CASE TO COURT." LEGAL BULLETIN 4, no. 8 (2023): 114–22. https://doi.org/10.5281/zenodo.11190399.
Pełny tekst źródłaSantini, Ario, and Kenneth A. Eaton. "An Introduction to Research for Primary Dental Care Clinicians." Primary Dental Care os18, no. 3 (2011): 127–32. http://dx.doi.org/10.1177/2050168411os1800312.
Pełny tekst źródłaSantini, Ario, and Kenneth A. Eaton. "An Introduction to Research for Primary Dental Care Clinicians." Primary Dental Care os18, no. 3 (2011): 133–35. http://dx.doi.org/10.1177/2050168411os1800315.
Pełny tekst źródłaVolkmer, Anna, David A. Copland, Maya L. Henry, et al. "COS-PPA: protocol to develop a core outcome set for primary progressive aphasia." BMJ Open 14, no. 5 (2024): e078714. http://dx.doi.org/10.1136/bmjopen-2023-078714.
Pełny tekst źródłaHladkykh, Dmytro M., Victoria Oleshko, and Nataliya Berladir. "Role of pembrolizumab in relapsed Hodgkin lymphoma patients." American Journal of BioMedicine 11, no. 4 (2023): 172–85. http://dx.doi.org/10.18081/2333-5106/2023.11/172.
Pełny tekst źródłaStoen, Ericson, Jodi Kagihara, Elena Shagisultanova, et al. "Real-world evidence from a University Hospital system regarding the uptake of adjuvant pertuzumab and/or neratinib before and after their FDA approval." Breast Cancer Research and Treatment 187, no. 3 (2021): 883–91. http://dx.doi.org/10.1007/s10549-021-06132-8.
Pełny tekst źródłaZhao, Jingxuan, Ilana Graetz, David Howard, Robin Yabroff, and Joseph Lipscomb. "Association of immune checkpoint inhibitor introduction and changes in survival disparities by health insurance coverage among individuals newly diagnosed with advanced cancers in the US." Journal of Clinical Oncology 42, no. 16_suppl (2024): 1580. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.1580.
Pełny tekst źródłaAlmusalami, Eman M., Mohammed I. Al-Bazroun, Amal I. Alhasawi, et al. "Acceptance, Advocacy, and Perception of Health Care Providers on COVID-19 Vaccine: Comparing Early Stage of COVID-19 Vaccination with Latter Stage in the Eastern Region of Saudi Arabia." Vaccines 11, no. 2 (2023): 488. http://dx.doi.org/10.3390/vaccines11020488.
Pełny tekst źródłaLee, Kyungsik, Hana Yoo, Sumin Shin, et al. "A Submodular Optimization Approach to Accountable Loan Approval." Proceedings of the AAAI Conference on Artificial Intelligence 38, no. 21 (2024): 22761–69. http://dx.doi.org/10.1609/aaai.v38i21.30310.
Pełny tekst źródła